163 related articles for article (PubMed ID: 28754895)
21. Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.
Trent NL; Menard JL
Physiol Behav; 2013 Feb; 110-111():20-9. PubMed ID: 23274501
[TBL] [Abstract][Full Text] [Related]
22. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
23. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
[TBL] [Abstract][Full Text] [Related]
24. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
Rimondini R; Thorsell A; Heilig M
Neurosci Lett; 2005 Feb; 375(2):129-33. PubMed ID: 15670655
[TBL] [Abstract][Full Text] [Related]
25. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
27. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
[TBL] [Abstract][Full Text] [Related]
28. Restraint stress potentiates neuropeptide Y-mediated impairment on spatial memory in rats.
Soares ES; Vanz F; Linartevichi VF; Cimarosti H; de Lima TCM
Behav Brain Res; 2022 Feb; 419():113705. PubMed ID: 34871704
[TBL] [Abstract][Full Text] [Related]
29. Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors.
Dautzenberg FM; Neysari S
Pharmacology; 2005 Dec; 75(1):21-9. PubMed ID: 15908753
[TBL] [Abstract][Full Text] [Related]
30. Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.
Pickens CL; Adams-Deutsch T; Nair SG; Navarre BM; Heilig M; Shaham Y
Neuroscience; 2009 Dec; 164(4):1398-406. PubMed ID: 19800945
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
Gibbs JL; Diogenes A; Hargreaves KM
Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
[TBL] [Abstract][Full Text] [Related]
32. Role of NPY Y1 receptor on acquisition, consolidation and extinction on contextual fear conditioning: dissociation between anxiety, locomotion and non-emotional memory behavior.
Lach G; de Lima TC
Neurobiol Learn Mem; 2013 Jul; 103():26-33. PubMed ID: 23603424
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat.
Chen SH; Fung PC; Cheung RT
Free Radic Biol Med; 2002 Apr; 32(8):776-84. PubMed ID: 11937303
[TBL] [Abstract][Full Text] [Related]
34. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Rangani RJ; Upadhya MA; Nakhate KT; Kokare DM; Subhedar NK
Peptides; 2012 Feb; 33(2):317-28. PubMed ID: 22266216
[TBL] [Abstract][Full Text] [Related]
35. Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats.
Thorsell A; Rimondini R; Heilig M
Neurosci Lett; 2002 Oct; 332(1):1-4. PubMed ID: 12377370
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
37. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Malmström RE; Balmér KC; Lundberg JM
Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide Y is Up-regulated and Induces Antinociception in Cancer-induced Bone Pain.
Diaz-delCastillo M; Christiansen SH; Appel CK; Falk S; Woldbye DPD; Heegaard AM
Neuroscience; 2018 Aug; 384():111-119. PubMed ID: 29852245
[TBL] [Abstract][Full Text] [Related]
39. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
40. Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes.
Rosmaninho-Salgado J; Cortez V; Estrada M; Santana MM; Gonçalves A; Marques AP; Cavadas C
Neuropeptides; 2012 Dec; 46(6):359-66. PubMed ID: 22981159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
